News

At Selexys, we are committed to advancing the understanding of inflammation and developing novel new products to treat inflammatory diseases. Our business is focused on helping patients who suffer these afflictions enjoy better and longer lives. Check our press releases below to check the status of our product development.

December 19, 2011

Selexys Pharmaceuticals Completes Phase I Clinical Study for Sickle Cell Drug
read full release »

May 4, 2011

Selexys Pharmaceuticals Initiates Enrollment in Phase I Clinical Study of SelG1
read full release »

November 3, 2010

Selexys receives Qualifying Therapeutic Discovery Project (QTDP) grant
read full release »

October 29, 2010

Selexys prepares claim for sickle cell drug
read full release »

June 16, 2009

Selexys secures seed money, grants for drug development
read full release »

April 28, 2009

Selexys receives $300,000 grant
read full release »

May 3, 2008

Project Boomerang targets highly skilled, former Oklahomans
read full release »

December 12, 2006

Selexys Pharmaceuticals Corporation Receives Additional State of Oklahoma Funding
read full release »

September 12, 2006

Selexys Pharmaceuticals Corporation Closes Initial Seed Round
read full release »